Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal motility regulatory network is a multi-component physiological system that governs the mechanical processing and transit of luminal contents (Furness, 2012, Journal of Internal Medicine). It consists of the enteric nervous system (ENS), often referred to as the 'second brain,' the interstitial cells of Cajal (ICC) acting as electrical pacemakers, and the gastrointestinal smooth muscle layers (Sanders et al., 2014, Nature Reviews Gastroenterology & Hepatology). This network integrates intrinsic sensory information with extrinsic autonomic input to coordinate complex motor patterns such as peristalsis and the migrating motor complex (Gershon, 2013, Journal of Clinical Investigation). Clinical manifestations of network failure include gastroparesis, chronic idiopathic constipation, and irritable bowel syndrome (Camilleri, 2012, NEJM). Pharmacological intervention typically targets specific molecular nodes within this network, such as 5-HT4 receptors to accelerate transit or mu-opioid receptors to slow it, rather than the network as a single entity (Ford et al., 2014, American Journal of Gastroenterology). Because this term describes a broad physiological system rather than a single therapeutic molecule, it is classified as a network rather than a discrete drug target.
Modulation of enteric neurotransmission and pacemaker activity via specific receptors (e.g., 5-HT4, Mu-opioid, D2) or ion channels to alter gastrointestinal transit time and contractile patterns (Camilleri, 2012, NEJM).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal motility regulatory network.